Articles In Press
Articles In Press are peer reviewed and have been accepted for publication. Please note that these versions may be subject to further edits before their final online publication. Nevertheless, Articles In Press are citable using the DOI. Upon the formal online publication, the article will no longer be listed here, but existing links will automatically redirect to the final version in the corresponding issue.
A Validated Interactive Google Colab Workflow for Segmentation and Quantitative Analysis of Multiplex Immunofluorescence and Chromogenic Immunohistochemistry
Quantitative analysis of multiplex immunofluorescence and chromogenic immunohistochemistry commonly requires specialized software, local installation, scripting experience, or substantial manual processing. Here, we describe a browser-based Google Colab workflow that enables researchers to perform cell segmentation, staining quantification, phenotypic classification, quality control, and data export through interactive controls without editing code or installing software locally.
The notebook provides separate branches for fluorescence and chromogenic analysis. The fluorescence branch supports multichannel images and z-stacks, segments nuclei using pretrained Cellpose models, constructs nuclear or expanded cell-measurement regions, and quantifies per-cell fluorescence intensity and morphology. Marker-positive, double-positive, and triple-positive populations can be classified using user-selected thresholds, and results can be exported as CSV, XLSX, or FCS 3.1 files. Technical concordance was evaluated using a publicly available 44-channel t-CyCIF tonsil image and its published single-cell measurements. DNA1 re-segmentation produced 61,173 objects, of which 17,614 were matched to published cells using predefined centroid-distance and area-ratio criteria. Continuous fluorescence agreement and independently thresholded positive-cell classifications were assessed across DNA1 and 26 biological-marker channels. The chromogenic branch was evaluated in two complementary settings. First, perinuclear measurements were compared with pathologist-assigned HER2 grades using a balanced set of 4,000 image patches. The workflow correctly reproduced the four HER2 grades in approximately seven out of ten patches, with stronger agreement for perinuclear measurements than for nuclear measurements. Second, the workflow was tested against Human Protein Atlas staining-intensity annotations across 1,709 cancer tissue cores, covering 22 antibodies and 20 cancer types. Agreement was above the level expected by chance and remained similar when thresholds were fitted on one subset of cores and evaluated on a separate subset of cores, indicating that the results were not driven solely by scoring the same samples used to set the thresholds. This workflow provides an accessible and reproducible starting point for quantitative fluorescence and chromogenic image analysis.
Cost-Effective Transient Expression of Viral Glycoproteins Using Mammalian Expi293F Cells
The efficacy of most recombinant viral vaccines relies on surface glycoproteins to induce immunity and protection from infection. However, many viral glycoproteins are notoriously difficult to manufacture both at lab and industrial scales for in vitro experiments and immunization studies. They usually comprise multiple subunits, the quaternary structure of which is often critical for the induction of relevant immune responses. Furthermore, they frequently contain complex, host-derived glycosylation patterns. Correct glycosylation, multimerization, and recapitulation of the native protein structure in a recombinant soluble form often depend on human-derived suspension cell culture. The associated high costs restrict the use of these systems to well-funded and/or specialized labs. Here, we describe the production of glycoproteins derived from diverse viruses (henipaviruses, filoviruses, human immunodeficiency virus, Andes virus, Crimean–Congo hemorrhagic fever virus, and hepatitis C virus) using human-derived Expi293F cells; we found these can be produced with existing infrastructure and commercially available components at less than 10% of the cost compared to conventional transfection protocols. This protocol combines general Expi293F cell culture principles with more economical and widely available reagents. First identified for the production of antibodies, it is now applied and expanded to produce a set of challenging recombinant viral proteins, not requiring any additional equipment beyond those necessary for basic suspension cell culture.
Capturing Proteins Co-Sorted into Budding Vesicles via an Integrated Proximity Labeling and In Vitro Vesicle Reconstitution Assay
Protein trafficking relies on the selective packaging of cargo into transport vesicles, yet the molecular machinery governing specific cargo sorting remains incompletely understood. Co-immunoprecipitation, although widely used, often fails to capture weak or transient interactions within dynamic vesicle populations. Conventional proximity labeling methods also fail to distinguish bona fide vesicle-associated interactors from proteins merely near a cargo. Here, we describe a stepwise protocol that integrates proximity biotinylation with an in vitro vesicle reconstitution assay to selectively capture proteins that are co-packaged with a cargo of interest into budding vesicles. The cargo is fused to ascorbate peroxidase 2 (APEX2), and the resulting cargo–APEX2 fusion mediates proximity biotinylation of nearby proteins in live cells. The cells are then subjected to a cell-free vesicle formation reaction, followed by affinity capture of biotinylated proteins that are specifically incorporated into vesicles. This strategy reduces background contributions. Validated here with ShhN-APEX2 in HEK293T cells, this assay is expected to be adaptable to other secretory cargoes and provides a platform for systematic identification of trafficking regulators in development and disease.
Generation, Cryopreservation, and Drug Assessment of 3D Tumor Spheroids Using the Spheromatrix Platform
Three-dimensional (3D) tumor spheroids provide tissue-like models for preclinical oncology, yet their scalable production, long-term preservation, and on-demand use remain technically demanding. This protocol describes the Spheromatrix, a paper-based platform combining wax-patterned hydrophilic U-wells with a custom 3D-printed cell loading device (Spherobox). The protocol covers Spherobox and U-well fabrication, uniform Spherobox-assisted cell seeding into the U-wells, spheroid culture, controlled-rate freezing, liquid nitrogen storage, rapid post-thaw recovery, and drug response assessment. The demonstrated 14 × 16 format provides 224 spatially separated U-wells for parallel spheroid generation and can be scaled by expanding the wax-patterned paper array. The platform was validated for spheroid generation using six cancer cell lines (MCF7, PC3, HeLa, SKBR3, HCT15, and U87) and the noncancerous MRC5 fibroblast cell line. U87 glioblastoma spheroids served as a proof-of-concept model for the complete cryopreservation-to-drug response assessment workflow and, following recovery, retained their morphology and metabolic activity and remained responsive to cisplatin and temozolomide. The compact, stackable format supports space-efficient generation, storage, and retrieval of ready-to-use 3D tumor models for drug screening and spheroid biobanking.
Cy5-Fluorescent EMSA for Characterization of G-Quadruplex Structures and DNA–Protein Interactions Without Radioisotopes
The characterization of DNA–protein interactions is fundamental to understanding the molecular mechanisms that regulate genome function. G-quadruplexes (G4s) are non-canonical nucleic acid secondary structures that influence diverse biological processes, including DNA replication, transcription, and DNA repair, primarily through their interactions with G-quadruplex-binding proteins (G4BPs). The electrophoretic mobility shift assay (EMSA) is one of the most widely used methods for studying DNA–protein interactions under native conditions. Conventional EMSA protocols commonly employ radioisotope-labeled oligonucleotides, which require specialized laboratory infrastructure, regulatory compliance, and radioactive waste disposal. Here, we describe a fluorescence-based EMSA protocol that uses commercially synthesized Cy5-labeled oligonucleotides for both the characterization of G4 structures and the analysis of DNA–protein interactions without the use of radioisotopes. G-rich oligonucleotides are folded under potassium-containing conditions and resolved by native polyacrylamide gel electrophoresis (PAGE), enabling discrimination between intramolecular and intermolecular G4 conformations based on their electrophoretic mobility. The folded G4 DNA can subsequently be incubated with purified proteins or cell lysates, and relative protein binding is detected by the reduced electrophoretic mobility of DNA–protein complexes. Fluorescent DNA and DNA–protein complexes are directly visualized using standard fluorescence gel imaging systems, eliminating the need for radioactive probe preparation while simplifying sample handling and data acquisition. This protocol provides a simple, sensitive, and reproducible approach for investigating G-quadruplex structures and their interactions with DNA-binding proteins and can be readily adapted to other structured or linear DNA substrates.
Producing High-Purity, Immobilized Enzymes on Inactivated Bacillus subtilis Using the Coated Bacterial Enzyme (CBE) Platform
The purification of industrial enzymes, such as β-galactosidase for lactose-reduced milk production, typically requires costly and time-consuming multi-step chromatography. Most purification protocols use two or more column fractionation steps and involve techniques such as gel filtration, ion exchange, and affinity chromatography, which are expensive and generally result in low yields. To address this limitation, we developed the Coated Bacterial Enzymes (CBEs) platform, which enables one-step purification and immobilization of recombinant enzymes fused to the SlpA cell wall-binding domain using chemically inactivated Bacillus subtilis as a low-cost biological carrier. This protocol describes the expression of the chimeric enzyme BbgII-SlpA (a β-galactosidase from Bifidobacterium bifidum) in Escherichia coli, the preparation of the bacterial carrier, the direct capture of the target enzyme from crude cell lysate onto the carrier surface, and the functional characterization of the resulting immobilized biocatalyst. The entire purification and immobilization process is completed in approximately 2 h after cell lysis. The procedure also includes an optional elution step to recover the purified enzyme in soluble form. The CBE platform offers a one-step, cost-effective, and scalable alternative for obtaining high-purity, immobilized enzymes with enhanced thermal stability and tolerance to inhibitory cations, making it suitable for industrial applications such as lactose hydrolysis.
Flow Cytometry Assessment of T-Cell Exhaustion Markers and Cytokine Production in Cryopreserved Mouse Splenocytes
Aging is associated with accumulating dysfunctional T cells, characterized by altered marker expression detectable by flow cytometry. However, since no individual marker reflects age-related processes specifically, assessing a combined set of markers is critical, yet often impractical on fresh cells when multiple panels or samples are involved. Here, we present a detailed protocol to comprehensively evaluate exhaustion markers and cytokine expression using cryopreserved mouse splenocytes and multi-parameter flow cytometry. The approach is validated by comparing cells isolated from young and aged mice.
Rapid Purification of Ion-Transporter Proteins in Arabidopsis thaliana
Plant ion transporters are membrane-localized proteins that play critical roles in nutrient uptake and distribution, ion homeostasis, and stomatal movement. To date, the majority of research on ion transporters has focused on regulation of their activity, post-translational modifications, and endomembrane trafficking. In such work, it is often necessary to purify the full-length proteins. However, these transporters typically contain multiple transmembrane (TM) domains and exhibit low solubility, making conventional purification methods inefficient. Thus, there is an urgent need to develop simple, rapid, and cost-effective approaches for extracting and purifying these proteins. Here, we present a detailed protocol for the extraction and purification of full-length ion transporters and demonstrate its utility by isolating the Na+/H+ antiporter SOS1 and the vacuolar metal transporter NRAMP3.
A Simplified Method for Verifying Tocopherol Biosynthesis-Related Genes by Transient Expression in Nicotiana benthamiana
Tocopherols are lipid-soluble antioxidants essential for both plants and animals that are present in all photosynthetic organisms. While most enzymes involved in the tocopherol biosynthesis pathway have been identified, those responsible for phytol production remain incompletely characterized, particularly across different plant species. To facilitate rapid screening of candidate genes involved in tocopherol synthesis, we present a protocol that combines Agrobacterium-mediated transient expression of exogenous proteins in Nicotiana benthamiana leaves with subsequent western blotting, subcellular colocalization analysis, and HPLC-based tocopherol quantification. This protocol allows researchers to assess whether a candidate protein is expressed, localizes to the chloroplast (the site of tocopherol biosynthesis), and alters tocopherol accumulation within 5–7 days. This method can also be applied for studying various other metabolites in transient assays, especially when stable transgenic lines are challenging to acquire.
Immobilization of Intact Ex Vivo Gonads From Caenorhabditis elegans for High-Resolution Live Microscopy
C. elegans has emerged as a key model organism for microscopy of intact meiotic nuclei, owing to its small number of chromosomes, transparency, ease of genetic manipulation, and linearly ordered stages of meiotic progression along its gonad. Most studies use either immunofluorescence of extruded and fixed gonad tissue or live imaging of fluorescently tagged proteins within the gonad of the living animal. These techniques enable high-resolution imaging and preserve native cellular dynamics, respectively. To combine these advantages, this protocol describes the methodology for ex vivo imaging of the C. elegans gonads for high-resolution live imaging, including laser-scanning confocal microscopy and single-molecule tracking microscopy. By using a physiologically matched medium, maintaining the gonad’s connection to the carcass, and providing mechanical support with a thin layer of petroleum jelly, we consistently maintain gonad integrity and meiotic function, as described by dynein-driven chromosome motion, in >70% of individual preparations and for >30 min. Advantages of this approach compared to intravital imaging include the ability to add membrane-permeable dyes, reduced aberrations and autofluorescent background, and convenient preparation.
A New PCR-Based Method for the Diagnosis of Leishmania tropica, Leishmania infantum, and Leishmania major Infections
Leishmaniases are neglected vector-borne diseases caused by protozoan parasites of the genus Leishmania, affecting both humans and animals in endemic regions worldwide. Beyond confirming the presence or absence of the parasite, accurate species identification is further essential for patient management, epidemiological surveillance, and monitoring of parasite circulation in natural reservoirs and vectors. Current molecular diagnostic approaches mainly rely on conventional PCR or qPCR assays, which frequently require additional post-amplification procedures, such as amplicon sequencing or RFLP analysis, to identify the Leishmania species. Moreover, species-identification methods based solely on amplicon size discrimination can lack sufficient resolution to reliably distinguish the diverse Leishmania species circulating in endemic regions, particularly those found in Morocco. The TIM assay (an acronym for tropica, infantum, major) provides a sensitive, robust, and flexible approach based on conventional PCR for the detection and identification of Leishmania parasites. It offers three complementary and adaptable strategies: enhanced sensitivity through an optional nested pre-amplification step (TIM1), rapid screening using a single multiplex reaction (TIM2), and accurate species discrimination through species-specific amplification (TIM3). Although initially developed to address human cutaneous leishmaniasis (CL) diagnostic needs in Morocco, the assay is broadly applicable to other endemic regions and can also be used for the detection of visceral leishmaniasis (VL) caused by L. infantum species. Its adaptability to field applications further supports its use in parasite surveillance and One Health strategies involving both wild and domestic animal reservoirs.
Measuring the ADP-Ribosylation-Dependent Release of PARP2 From DNA Using Stopped-Flow Fluorescence Polarization
The ADP-ribosyltransferase PARP2 plays a major role in DNA damage repair mechanisms. It recognizes damaged DNA, resulting in poly-ADP-ribosylation (PARylation) of target proteins and itself. The automodification of PARP2, especially at N-terminal serine residues in the presence of histone PARylation factor 1 (HPF1), leads to its release from DNA. Here, we describe a stopped-flow-based fluorescence polarization method for the real-time measurement of PARP2 release from DNA damage by monitoring the change in fluorescence anisotropy of fluorescein-labeled DNA. The method is based on rapid mixing of a preformed DNA-PARP2-HPF1 complex with NAD+ and monitoring the release of PARP2 from DNA. The stopped-flow-based fluorescence anisotropy method provides a fast and sensitive measurement of PARP2 release from DNA that can be widely used to study the effect of PARP2 mutants or inhibitors on PARP2 activity and dissociation from DNA.
Measuring Functional and Structural Muscle Properties in Drosophila Larvae for Testing Genetic Variants Involved in Neuromuscular Disorders
Drosophila melanogaster has emerged as a powerful model for investigating the genetic control of muscle development and muscle function in both normal and pathological conditions. To date, several Drosophila models of human neuromuscular disorders (NMDs) have been generated and characterized, allowing a better understanding of disease mechanisms, improving diagnosis, and testing of new therapeutic strategies. Conserved genes encoding large muscle proteins such as Titin or Ryanodine receptor (RyR) harbor hundreds of variant mutations, many of which remain variants of unknown significance (VUS). Here, we describe procedures for generating a CRISPR-engineered Drosophila model of a VUS and an integrated workflow for quantitative assessment of functional and structural muscle properties, providing an indication of VUS pathogenicity. The protocol combines larval locomotor assays, muscle morphometry, and structural muscle properties assessment. The workflow enables systematic evaluation of muscle structure and function and provides a versatile platform for studying genetic variants and their involvement in NMDs.
Elimination of cis-cleavage in CRISPR Diagnostics for One-Pot Rapid Nucleic Acid Detection
CRISPR/Cas12a-based nucleic acid detection enables rapid molecular diagnostics, yet conventional two-step assays are slow and contamination-prone, while one-pot methods suffer from Cas12a cis-cleavage of amplicons. This protocol presents a one-pot, cis-cleavage-free SCas12a system using a bipartite split crRNA—comprising a scaffold and 20-nt spacer—that directs Cas12a to PAM-free double-stranded DNA with no detectable cis-cleavage under the tested conditions while maintaining trans-cleavage of ssDNA reporters. We detail RNA/primer design, ortholog expression and purification, RNP assembly, and integration with RPA, RT-RPA, or LAMP for unified detection and single-nucleotide variant (SNV) genotyping. The original study demonstrated improved sensitivity and single-base discrimination in selected model assays, with clinical application examples involving HPV16, SARS-CoV-2, and TP53. These results support potential point-of-care adaptation; broader clinical performance and portable readout remain to be validated.
Human iPSC Line SCTi003-A Differentiation Into Kidney Organoids
Kidney organoids derived from human induced pluripotent stem cells (hiPSCs) have emerged as valuable tools for studying human kidney development, disease mechanisms, and therapeutic responses. However, widespread application of these models has been limited by variability in differentiation efficiency, organoid composition, reproducibility, and scalability across existing protocols. Robust and standardised methods are therefore needed to improve experimental consistency and facilitate wider adoption of kidney organoid systems in basic and translational research. Here, we describe an optimised and reproducible protocol for differentiating a commercially available hiPSC SCTi003-A line into kidney organoids (KiO). The protocol builds upon earlier kidney differentiation frameworks and involves directed induction of the posterior primitive streak, intermediate mesoderm specification, and subsequent three-dimensional organoid assembly. Through systematic optimisation of differentiation media, CHIR99021 concentration and timing, growth factor supplementation, and culture format, we established a standardised workflow that yields reproducible nephron and collecting duct structures. The protocol is compatible with air–liquid interface (ALI) culture and scalable suspension-based “mini-organoid” (mKiO) and monolayer culture formats that support high-content and high-throughput applications. This validated protocol provides a reliable and accessible platform for generating human KiO, addressing key limitations of reproducibility, scalability, and assay compatibility in existing approaches, and supporting future studies of kidney development, inherited kidney diseases, and preclinical drug testing.
Preparation of Moss Tissue for Cryo-Electron Tomography by High-Pressure Freezing, Focused Ion Beam Milling, and Lift-Out
Cryo-electron tomography (cryo-ET) is a powerful imaging technique that allows visualizing the molecular landscape within cells. In contrast to traditional preparations for electron microscopy deploying chemical fixation and contrasting agents, cryo-ET directly images cryo-fixed, i.e., vitrified samples, providing a faithful and near-native representation of cellular ultrastructure and its macromolecular constituents. While cryo-ET in combination with thinning by focused ion beam (FIB) milling is well established for single small or thin cells that can be vitrified by plunge freezing, its application to tissues is still challenging in terms of vitrification and thinning strategies. Intact plant tissues are particularly difficult, due to their relatively large cell size and the presence of vacuoles, which often occupy a large fraction of cells and usually do not vitrify. Here, we describe two methods for vitrification of the filamentous tissue (protonemata) of moss (Physcomitrium patens) by two high-pressure freezing (HPF) approaches. We also describe in detail how to prepare thin sections (lamellae) suitable for cryo-ET data acquisition by either on-grid FIB milling or lift-out with three different attachment methods that can be applied depending on skill and experimental setup of users. For the preparation of lift-out lamellae, we introduce an additional trimming step that can help to improve lamella quality. We illustrate how subcellular structures can be targeted by aiming for cell junctions using cryo-fluorescence light microscopy. The different preparation procedures can be used for samples of different sizes and other multicellular systems.
Key features
• This protocol builds on serial lift-out [1] but was adapted for moss and can be applied to other species and tissues, as described in [2].
• We describe two high-pressure freezing approaches for different specimen sizes and procedures for sample screening and targeted lamella preparation aided by cryo-fluorescence light microscopy.
• We describe on-grid lamella preparation and three lift-out approaches with a novel, more robust attachment mode.
• By applying an additional trimming step for lift-out sections, this protocol was optimized for lamella quality rather than quantity.
PCR-Guided Isolation of Leptospira Strains From Refrigerated Serum Samples for Serogroup and Genomic Characterization
Leptospirosis is a widespread zoonotic disease caused by pathogenic bacteria of the genus Leptospira. The isolation and comprehensive characterization of circulating strains within a region are essential for understanding the local epidemiology and improving public health surveillance. Historically, whole blood has been the specimen of choice for isolation; however, its efficiency can be limited by the presence of inhibitory substances in the sample, and Leptospira viability may depend on rapid processing and inoculation. Here, we present an in-house culture protocol for the isolation of Leptospira from serum samples previously maintained under refrigeration (i.e., 4–8 °C) for up to 10 days. The protocol employs a real-time PCR-guided strategy by first screening specimens for the lipL32 gene. Positive samples are then inoculated into specialized EMJH media supplemented with AFAS and EMJH+AFAS supplemented with STAFF antibiotic cocktail, followed by incubation at 30 °C for up to six months. Growth is monitored weekly through visual inspection and, once turbid, the presence of Leptospira is determined via dark-field microscopy prior to downstream serogroup and genomic characterization. A significant advantage of this method is the successful recovery of viable Leptospira from non-fresh serum specimens stored under refrigeration, even in samples with low bacterial loads. Additionally, the protocol facilitates broader surveillance by repurposing serum samples already collected for routine serology, increasing the probability of identifying diverse strains without further clinical collection
Semi-Automated Multiplex Workflow for Functional In Vitro Testing of Chemotherapeutic Treatments in Primary, Patient-Derived Cancer Organoids
Most existing preclinical models have been limited in their predictive value to mimic patients’ responses, which is a major drawback in drug development and the identification of predictive biomarkers. To overcome these limitations, patient-derived three-dimensional in vitro models have been proposed. One of them is the organoid model, which preserves the original cellular heterogeneity and recapitulates epithelial architecture and functionality. Recently, studies using patient-derived organoids for drug screening applications have increased in quantity, and organoids have already been applied to pancreatic, colon, and lung cancers and female gynecological malignancies. Here, we established a multiplex workflow to analyze longitudinal therapeutic effects of anti-cancer therapeutics on organoid growth, viability, and cytotoxicity by combining state-of-the-art viability measurement with automated live cell imaging. This workflow can be used for the prediction of patient-specific treatment response, high-throughput screening of potential anticancer drugs, and downstream analysis to identify novel therapeutic targets.
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics